Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sareum Hldgs Plc

SAR
Current price
25.1 GBP -0.15 GBP (-0.59%)
Last closed 25.25 GBP
ISIN GB00BMC3RJ87
Sector Healthcare
Industry Biotechnology
Exchange London Exchange
Capitalization 30 951 651 GBP
Yield for 12 month -58.17 %
1Y
3Y
5Y
10Y
15Y
SAR
21.11.2021 - 28.11.2021

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases. Its also developing SDC-1802, a TYK2/JAK1 inhibitor, which is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage, oral, selective Checkpoint kinase 1 (Chk1) inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom. Address: Langford Arch, Cambridge, United Kingdom, CB22 3FX

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

138.53 GBP

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-1 013 GBP

Last Year

-1 013 GBP

Current Quarter

Last Quarter

-1 013 GBP

Key Figures SAR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 631 187 GBP
Operating Margin TTM
PE Ratio
Return On Assets TTM -119.44 %
PEG Ratio
Return On Equity TTM -209.37 %
Wall Street Target Price 138.53 GBP
Revenue TTM 47 805 GBP
Book Value 0.02 GBP
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 47 805 GBP
Earnings per share -0.041 GBP
Diluted Eps TTM -0.041 GBP
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SAR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SAR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 01.03.2022
Dividend Date

Stock Valuation SAR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4892.3053
Price Sales TTM 4491.973
Enterprise Value EBITDA -17.1315
Price Book MRQ 14.4574

Financials SAR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SAR

For 52 weeks

10.13 GBP 78.99 GBP
50 Day MA 27.19 GBP
Shares Short Prior Month
200 Day MA 30.56 GBP
Short Ratio
Shares Short
Short Percent